Direxion mRNA ETF

Rentabilität für sechs Monate: 0%
Industrie: Health & Biotech Equities

BeiGene, Ltd.
Vertex
Alnylam Pharmaceuticals, Inc.
BioNTech SE
Moderna
Arcturus Therapeutics Holdings Inc.
PTC Therapeutics, Inc.
Intellia Therapeutics, Inc.
Sarepta Therapeutics, Inc.
Maravai LifeSciences Holdings, Inc.
Ionis Pharmaceuticals
Sangamo Therapeutics, Inc.
Arrowhead Pharmaceuticals, Inc.
Ausruhen
BeiGene, Ltd.: 6.7%Vertex: 6.6%Alnylam Pharmaceuticals, Inc.: 6.3%BioNTech SE: 6.1%Moderna: 6%Arcturus Therapeutics Holdings Inc.: 5%PTC Therapeutics, Inc.: 4.9%Intellia Therapeutics, Inc.: 4.8%Sarepta Therapeutics, Inc.: 4.7%Maravai LifeSciences Holdings, Inc.: 4.6%Ionis Pharmaceuticals: 4.1%Sangamo Therapeutics, Inc.: 4%Arrowhead Pharmaceuticals, Inc.: 3.7%Ausruhen: 32.8%Anteil nach Unternehmen teilende.porti.ru
SVG speichern
PNG speichern
CSV speichern
NameIndustrieAktie, %P/BVP/SP/EEV/EbitdaDividendenrendite
BeiGene, Ltd. BeiGene, Ltd. Healthcare 6.65 5.42 7.8 0 -15.07 0
Vertex Vertex Healthcare 6.6 6 10.73 29.17 24.42 0
Alnylam Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Healthcare 6.32 -108.14 13.05 0 -112.79 0
BioNTech SE BioNTech SE Healthcare 6.14 1.36 9.62 24.73 -46.17 0
Moderna Moderna Healthcare 5.95 2.68 4.93 8.96 -11.06 0
Arcturus Therapeutics Holdings Inc. Arcturus Therapeutics Holdings Inc. Healthcare 4.96 3.03 5.35 49.99 -441.27 0
PTC Therapeutics, Inc. PTC Therapeutics, Inc. Healthcare 4.89 -2.52 2.2 0 -16.73 0
Intellia Therapeutics, Inc. Intellia Therapeutics, Inc. Healthcare 4.77 2.65 76.74 0 -5.28 0
Sarepta Therapeutics, Inc. Sarepta Therapeutics, Inc. Healthcare 4.65 10.17 6.87 55.57 -36.23 0
Maravai LifeSciences Holdings, Inc. Maravai LifeSciences Holdings, Inc. Healthcare 4.55 1.11 3.03 7.19 20.45 0
Ionis Pharmaceuticals Ionis Pharmaceuticals Healthcare 4.07 8.87 7.4 122.59 -13.44 0
Sangamo Therapeutics, Inc. Sangamo Therapeutics, Inc. Healthcare 3.98 20.73 8.17 0 -4.39 0
Arrowhead Pharmaceuticals, Inc. Arrowhead Pharmaceuticals, Inc. Healthcare 3.66 12.14 653.4 478.56 -4.86 0
67.19-2.8162.2559.75-50.960

Bezahlen Sie Ihr Abonnement

Weitere Funktionen und Daten zur Unternehmens- und Portfolioanalyse sind im Abonnement verfügbar